To validate the levels of APOL1 expression in renal tissues of FSGS patients carrying the mutation, we obtained deidentified, formalin-fixed, paraffin-embedded human kidney specimens from the proband, FSGS without APOL1 mutation, and healthy control (Figure 1E). The gene discussed is APOL1; the disease is focal segmental glomerulosclerosis.